133240-06-9,MFCD01632103
Catalog No.:AA0014D5

133240-06-9 | 2-Ethyl-5,7-dimethyl-3h-imidazo[4,5-b]pyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$16.00   $12.00
- +
250mg
98%
in stock  
$39.00   $27.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0014D5
Chemical Name:
2-Ethyl-5,7-dimethyl-3h-imidazo[4,5-b]pyridine
CAS Number:
133240-06-9
Molecular Formula:
C10H13N3
Molecular Weight:
175.2303
MDL Number:
MFCD01632103
SMILES:
CCc1nc2c([nH]1)nc(cc2C)C
Properties
Computed Properties
 
Complexity:
183  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.3  

Downstream Synthesis Route

[1]Heitsch,Holger;Becker,ReinhardH.A.;Kleemann,Heinz-Werner;Wagner,Adalbert[BioorganicandMedicinalChemistry,1997,vol.5,#4,p.673-678]

[2]Mantlo,NathanB.;Chakravarty,PrasunK.;Ondeyka,DebraL.;Siegl,PeterK.S.;Chang,RaymondS.;etal.[JournalofMedicinalChemistry,1991,vol.34,#9,p.2919-2922]

[1]Senanayake,ChrisH.;Fredenburgh,LauraE.;Reamer,RobertA.;Liu,Ji;Larsen,RobertD.;Verhoeven,ThomasR.;Reider,PaulJ.[TetrahedronLetters,1994,vol.35,#32,p.5775-5778]

[2]CurrentPatentAssignee:UNIVERSITYOFMONTREAL;BRISTOL-MYERSSQUIBBCO-WO2018/5591,2018,A1Locationinpatent:Page/Pagecolumn93

[3]Senanayake,ChrisH.;Fredenburgh,LauraE.;Reamer,RobertA.;Liu,Ji;Roberts,F.Edward;Humphrey,Guy;Thompson,AndrewS.;Larsen,RobertD.;Verhoeven,ThomasR.;Reider,PaulJ.;Shinkai,Ichiro[Heterocycles,1996,vol.42,#2,p.821-830]

[4]Miltz,Wolfgang;Velcicky,Juraj;Dawson,Janet;Littlewood-Evans,Amanda;Ludwig,Marie-Gabrielle;Seuwen,Klaus;Feifel,Roland;Oberhauser,Berndt;Meyer,Arndt;Gabriel,Daniela;Nash,Mark;Loetscher,Pius[BioorganicandMedicinalChemistry,2017,vol.25,#16,p.4512-4525]

[1]Dhanoa;Bagley;Chang;Lotti;Chen;Kivlighn;Zingaro;Siegl;Chakravarty;Patchett;Greenlee[JournalofMedicinalChemistry,1993,vol.36,#23,p.3738-3742]

[1]JournalofMedicinalChemistry,1993,vol.36,p.4239-4249

[1]CurrentPatentAssignee:KIRINHOLDINGSCO.,LTD.;KyowaKirin(in:KirinHoldings)-EP1724271,2006,A1Locationinpatent:Page/Pagecolumn57

[2]Sircar;Winters;QuinIII;Lu;Major;Panek[JournalofMedicinalChemistry,1993,vol.36,#12,p.1735-1745]

[3]Dhanoa,DaljitS.;Bagley,ScottW.;Chang,RaymondS.L.;Lotti,VictorJ.;Chen,Tsing-Bau;etal.[JournalofMedicinalChemistry,1993,vol.36,#26,p.4239-4249]

Literature

Title: 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.

Journal: Journal of medicinal chemistry 20070222

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:133240-06-9 Molecular Formula|133240-06-9 MDL|133240-06-9 SMILES|133240-06-9 2-Ethyl-5,7-dimethyl-3h-imidazo[4,5-b]pyridine
Catalog No.: AA0014D5
133240-06-9,MFCD01632103
133240-06-9 | 2-Ethyl-5,7-dimethyl-3h-imidazo[4,5-b]pyridine
Pack Size: 100mg
Purity: 98%
in stock
$16.00 $12.00
Pack Size: 250mg
Purity: 98%
in stock
$39.00 $27.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0014D5
Chemical Name: 2-Ethyl-5,7-dimethyl-3h-imidazo[4,5-b]pyridine
CAS Number: 133240-06-9
Molecular Formula: C10H13N3
Molecular Weight: 175.2303
MDL Number: MFCD01632103
SMILES: CCc1nc2c([nH]1)nc(cc2C)C
Properties
Complexity: 183  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.3  
Downstream Synthesis Route
50850-16-3    802294-64-0    133240-06-9 

[1]Heitsch,Holger;Becker,ReinhardH.A.;Kleemann,Heinz-Werner;Wagner,Adalbert[BioorganicandMedicinalChemistry,1997,vol.5,#4,p.673-678]

[2]Mantlo,NathanB.;Chakravarty,PrasunK.;Ondeyka,DebraL.;Siegl,PeterK.S.;Chang,RaymondS.;etal.[JournalofMedicinalChemistry,1991,vol.34,#9,p.2919-2922]

116636-30-7    123-62-6    133240-06-9 

[1]Senanayake,ChrisH.;Fredenburgh,LauraE.;Reamer,RobertA.;Liu,Ji;Larsen,RobertD.;Verhoeven,ThomasR.;Reider,PaulJ.[TetrahedronLetters,1994,vol.35,#32,p.5775-5778]

[2]CurrentPatentAssignee:UNIVERSITYOFMONTREAL;BRISTOL-MYERSSQUIBBCO-WO2018/5591,2018,A1Locationinpatent:Page/Pagecolumn93

[3]Senanayake,ChrisH.;Fredenburgh,LauraE.;Reamer,RobertA.;Liu,Ji;Roberts,F.Edward;Humphrey,Guy;Thompson,AndrewS.;Larsen,RobertD.;Verhoeven,ThomasR.;Reider,PaulJ.;Shinkai,Ichiro[Heterocycles,1996,vol.42,#2,p.821-830]

[4]Miltz,Wolfgang;Velcicky,Juraj;Dawson,Janet;Littlewood-Evans,Amanda;Ludwig,Marie-Gabrielle;Seuwen,Klaus;Feifel,Roland;Oberhauser,Berndt;Meyer,Arndt;Gabriel,Daniela;Nash,Mark;Loetscher,Pius[BioorganicandMedicinalChemistry,2017,vol.25,#16,p.4512-4525]

133240-06-9    137421-55-7    137421-56-8 

[1]Dhanoa;Bagley;Chang;Lotti;Chen;Kivlighn;Zingaro;Siegl;Chakravarty;Patchett;Greenlee[JournalofMedicinalChemistry,1993,vol.36,#23,p.3738-3742]

133240-06-9    141281-38-1    151954-41-5 

[1]JournalofMedicinalChemistry,1993,vol.36,p.4239-4249

133240-06-9    100-11-8    137421-60-4 

[1]CurrentPatentAssignee:KIRINHOLDINGSCO.,LTD.;KyowaKirin(in:KirinHoldings)-EP1724271,2006,A1Locationinpatent:Page/Pagecolumn57

[2]Sircar;Winters;QuinIII;Lu;Major;Panek[JournalofMedicinalChemistry,1993,vol.36,#12,p.1735-1745]

[3]Dhanoa,DaljitS.;Bagley,ScottW.;Chang,RaymondS.L.;Lotti,VictorJ.;Chen,Tsing-Bau;etal.[JournalofMedicinalChemistry,1993,vol.36,#26,p.4239-4249]

Literature fold

Title: 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.

Journal: Journal of medicinal chemistry20070222

Building Blocks More >
1214331-63-1
1214331-63-1
2-Fluoro-3-trifluoromethyltoluene
AA0014PF | MFCD13185663
1214377-09-9
1214377-09-9
3,5-Difluoroisonicotinonitrile
AA0014VG | MFCD13176565
1215205-88-1
1215205-88-1
4-Bromo-2-mercapto-6-(trifluoromethyl)benzothiazole
AA00153S | MFCD13195699
1216394-63-6
1216394-63-6
2(1H)-Quinolinone, 7-[4-[[2-[(2,3-dichlorophenyl)amino]ethyl]amino]butoxy]-3,4-dihydro-
AA0015DH | MFCD21496423
1217500-87-2
1217500-87-2
6-Chloro-4-(trifluoromethyl)pyridine-3-boronic acid
AA0015P8 | MFCD12546506
121786-39-8
121786-39-8
D-Cyclopropylalanine
AA0015YO | MFCD02259520
1218790-93-2
1218790-93-2
2,3-Dihydro-5-furylboronic acid
AA001678 | MFCD13195681
1219741-94-2
1219741-94-2
4-(Cyclopropyl)phenylboronic acid pinacol ester
AA0016F2 | MFCD10698529
1221171-91-0
1221171-91-0
6-Chloro-2-(trifluoromethoxy)nicotinic acid
AA0016P1 | MFCD22571781
122307-41-9
122307-41-9
4-Chloro-3-methoxy-2-methylpyridine n-oxide
AA00170G | MFCD03093995
Submit
© 2017 AA BLOCKS, INC. All rights reserved.